Supply Chain

The World Health Organization will conduct a review of pharmaceutical giant Sanofi's dengue vaccine by year-end after evidence surfaced suggesting the vaccine could worsen the disease in some cases, according to Reuters.

Walgreens unveiled a rebranding strategy Monday aimed at attracting a younger customer demographic to remain competitive in the retail pharmacy sphere, reports CNBC.

Here are five drug and medical device companies that made headlines in the past week. 

Hospitals across the U.S. are already facing critical shortages of IV fluids after Hurricane Maria damaged manufacturing plants in Puerto Rico, and now the FDA is warning of a new product shortage exacerbated by the storm — injectable amino acids…

Sanofi, a French pharmaceutical company, halted the development and production of an experimental Clostridium difficile vaccine Friday after preliminary results of a late-stage trial revealed a low probability for success, according to Reuters.

The FDA approved Sublocade, Indivior's once-monthly buprenophine injection, to treat opioid use disorder in adults with moderate-to-severe addiction.

Here are the four latest drugs or medical devices approved by the FDA since Nov. 17.

The FDA approved Foundation Medicine's cancer gene test Thursday. CMS also proposed national coverage of the test for Medicare beneficiaries with advanced cancer.

A national saline bag shortage related to manufacturing delays in Puerto Rico most captured readers' attention in November.

Amazon has reportedly held preliminary discussions with several generic drug manufacturers regarding the company's potential foray into the pharmacy business, sources familiar with the matter told CNBC.